REGISTER

FR
Search
×
FR

Placeholder headline

This is just a placeholder headline

API MPMS CH 22.6: Testing Protocols for Gas Chromatographs : Reaffirmed

$

192

BUY NOW

Placeholder headline

This is just a placeholder headline

API RP 1174: Onshore Hazardous Liquid Pipeline Emergency Preparedness and Response : Reaffirmed

$

182

BUY NOW

Placeholder headline

This is just a placeholder headline

API STD 624: Type Testing of Rising Stem Valves Equipped with Flexible Graphite Packing for Fugitive

$

171

BUY NOW

Placeholder headline

This is just a placeholder headline

API STD 20G: Welding Services for Equipment used in the Petroleum and Natural Gas Industry : Reaffirmed

$

164

BUY NOW

Placeholder headline

This is just a placeholder headline

API STD 624: Errata 2

$

0.00

BUY NOW

Placeholder headline

This is just a placeholder headline

API RP 1173: Pipeline Safety Management Systems

$

167

BUY NOW

ISO 22456:2021

ISO 22456:2021 Sterilization of healthcare products – Microbiological methods- Guidance on conducting bioburden determinations and tests of sterility for biologics and tissue-based products

CDN $173.00

SKU: 33aeb37d974f Categories: ,

Description

1.1.1 This document provides guidance for bioburden testing and tests of sterility for biologics and tissue-based products, where this testing is in relation to product sterilization.

NOTE This document is intended to be used in conjunction with ISO 11737-1 and ISO 11737-2.

1.1.2 Guidance in this document can be applicable to biologics and tissue-based products that are not sterile but are microbiologically controlled.

Edition

1

Published Date

2021-03-19

Status

PUBLISHED

Pages

13

Language Detail Icon

English

Format Secure Icon

Secure PDF

Abstract

1.1.1 This document provides guidance for bioburden testing and tests of sterility for biologics and tissue-based products, where this testing is in relation to product sterilization.

NOTE This document is intended to be used in conjunction with ISO 11737-1 and ISO 11737-2.

1.1.2 Guidance in this document can be applicable to biologics and tissue-based products that are not sterile but are microbiologically controlled.

Previous Editions

Can’t find what you are looking for?

Please contact us at: